There's still little evidence the malaria drug hydroxychloroquine works to combat the coronavirus
Sen. Ron Johnson is organizing a letter from physicians to push President Donald Trump to increase access to the malaria drug hydroxychloroquine, despite scant evidence that it’s an effective treatment for coronavirus.
Johnson has long sought to loosen FDA restrictions; he helped write "right to try" legislation to expand access to experimental drugs and he cites patients' right to try in this latest campaign. Johnson’s letter argues that restricting the drug to hospitalized patients results in the “loss of the critical early window of opportunity” to prevent the spread of the virus and reduce hospitalizations.
Johnson’s office said that so far, the letter has the backing of 776 practicing physicians. He’s already submitted it to the White House but is collecting more signatures until Trump responds.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Rupert Grint, aka Ron Weasley, and Georgia Groome Are Expecting Their First ChildFingers crossed this baby is a Gryffindor! 👶🎉
Lire la suite »
Hydroxychloroquine Abuse Up Since Trump First Mentioned Drug, U.S. Poison Centers SayI’m a San Francisco-based reporter covering breaking news at Forbes. Previously, I’ve reported for USA Today, Business Insider, The San Francisco Business Times and San Jose Inside. I studied journalism at Syracuse University’s S.I. Newhouse School of Public Communications and was an editor at The Daily Orange, the university’s independent student newspaper. Follow me on Twitter rachsandl or shoot me an email rsandlerforbes.com.
Lire la suite »
Sanofi will donate 100 million doses of hydroxychloroquine to 50 countriesFrench pharmaceutical giant Sanofi said Friday it had decided to donate 100 million doses of hydroxychloroquine, the decades-old anti-malaria drug touted by some as a potential weapon against the novel coronavirus, across 50 countries.
Lire la suite »
Hydroxychloroquine trial gets French president's attention as 460,000 sign petition supporting treatmentEmmanuel Macron's interest in the drug has highlighted disagreements between medical professionals over the drug's reported effectiveness.
Lire la suite »
Exclusive: Amneal running out of hydroxychloroquine raw material due to Finnish restrictionsAmneal Pharmaceuticals could soon run out of the raw ingredients to make more of the antimalarial drug hydroxychloroquine that has been touted as a potential treatment for COVID-19 because Finland is keeping the drug for domestic use, according to the generic drugmaker's chief executives.
Lire la suite »
NIH begins trial to test hydroxychloroquine for treating COVID-19The National Institutes of Health (NIH) said on Thursday it was testing anti-malaria drug hydroxychloroquine for treating COVID-19, days after several U.S. doctors said they were using the drug on infected patients without evidence that it worked.
Lire la suite »